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Abstract
Background:  Retroviral Gag determines virus assembly at the plasma membrane and the
formation of virus-like particles in intracellular multivesicular bodies. Thereby, retroviruses exploit
by interaction with cellular partners the cellular machineries for vesicular transport in various ways.
Results: The retroviral Gag precursor protein drives assembly of murine leukaemia viruses (MLV)
at the plasma membrane (PM) and the formation of virus like particles in multivesicular bodies
(MVBs). In our study we show that caveolin-1 (Cav-1), a multifunctional membrane-associated
protein, co-localizes with Gag in a punctate pattern at the PM of infected NIH 3T3 cells. We
provide evidence that Cav-1 interacts with the matrix protein (MA) of the Gag precursor. This
interaction is mediated by a Cav-1 binding domain (CBD) within the N-terminus of MA.
Interestingly, the CBD motif identified within MA is highly conserved among most other γ-
retroviruses. Furthermore, Cav-1 is incorporated into MLV released from NIH 3T3 cells.
Overexpression of a GFP fusion protein containing the putative CBD of the retroviral MA resulted
in a considerable decrease in production of infectious retrovirus. Moreover, expression of a
dominant-negative Cav-1 mutant affected retroviral titres significantly.
Conclusion: This study demonstrates that Cav-1 interacts with MLV Gag, co-localizes with Gag
at the PM and affects the production of infectious virus. The results strongly suggest a role for Cav-
1 in the process of virus assembly.
Background
The Gag protein precursor is a polyprotein consisting of
matrix protein (MA), protein p12, capsid protein (CA)
and nucleocapsid protein (NC) and represents a principal
actor in retrovirus assembly at the plasma membrane
(PM). The Gag precursor is synthesized on free ribosomes
and myristoylated at glycin 2 in MA. Fatty acylation is suf-
ficient to localize Gag at the plasma membrane, where in
the presence of the envelope (Env) proteins viral particles
assemble. In the final stage of budding a membrane fis-
sion event is required for efficient separation of newly syn-
thesized retroviruses. Concurrent with budding, the Gag
polyprotein is cleaved by the retroviral protease into MA,
CA, NC and other virus-specific Gag derived proteins. Dis-
tinct regions in the Gag protein were identified which
mediate membrane binding, multimerization and induce
separation of nascent virus particles from the cell [1].
Gag alone is sufficient to induce the formation of virus-
like particles (VLPs) [1]. The formation of infectious par-
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ticles, however, requires co-localization of Env and Gag
and occurs in a cell-dependent manner either at the
plasma membrane or at internal membranes. Mutational
analysis of Gag of certain retroviruses defined several
regions important for Gag transport and efficient mem-
brane anchoring, as mutant viruses were blocked in mem-
brane association or redirected to multivesicular bodies
(MVBs) localized in the cytoplasm. It has been shown,
that myristoylation of Pr65gag at Gly2 at the aminotermi-
nus of the viral MA is substantial for Moloney murine leu-
kaemia virus (MoMLV) particle formation and budding
[2,3], and is required for efficient binding to the plasma
membrane. In addition, a run of basic residues or a cluster
of lipophilic amino acids close to the aminoterminus are
involved in Gag transport to the site of virus assembly [4-
8] However, the requirement for fatty acylation can be
overcome by other molecules. Thus, protein-protein inter-
actions have been postulated to be necessary for efficient
protein localization in lipid rafts [9].
Surprisingly, Gag transport turned out to be a complex
process involving several cellular proteins. Early experi-
ments with MLV and Rous sarcoma virus (RSV) demon-
strated that deletion of a region located between MA and
CA affected virus assembly. The same was true for human
immunodeficiency virus (HIV) when a region at the car-
boxy-terminus of the Gag precursor was deleted. These
early notions led to the identification of L-domains which
recruit the cellular machinery for intravesicular transport
of Gag [reviewed in 10,11]. The identified L-domains dif-
fer in their sequence within the retrovirus family and each
retroviral L-domain binds specific factors to redirect Gag
into the MVB pathway, thereby directing the budding and
egress of virions. The subject is still puzzling, as viral Gag
proteins contain several interacting motifs and their
importance varies in different retroviruses [12].
Formation of infectious MLV as well as successful pseudo-
typing of MLV vectors requires Env co-colocalization with
Gag [13,14]. Moreover, incorporation of cellular mem-
brane proteins into virions seems to be dependent on co-
localization. Interestingly, the incorporation reflects the
cell type, intracellular transport and the platform of
assembly and budding. Lipid rafts have been suggested as
portals for retrovirus exit. Env localization in lipid rafts
has been demonstrated for ecotropic MoMLV [15] as well
as for amphotropic 4070A MLV more recently [16].
When studying 4070A Env localization in infected
NIH3T3 cells, we noticed co-localization of Env with Cav-
1, a multi-functional membrane protein. Cav-1 is present
in lipid rafts and its oligomerization leads to caveolae for-
mation. Caveolae are the main actors for a clathrin-inde-
pendent endocytic pathway, first identified for
internalization of GPI anchored proteins [17]. Moreover,
Cav-1 functions as scaffolding protein to organize and
concentrate a growing list of proteins involved in diverse
signaling processes. Finally, Cav-1 is involved in choles-
terol transport [18].
We wondered whether the co-localization of Cav-1 and
4070A Env in the PM of mouse NIH3T3 cells results in
release of 4070A MLV (referred to as A-MLV) containing
Cav-1. Here, we proved the presence of considerable
amounts of Cav-1 within A-MLV as well as MoMLV. Fur-
thermore, MLV Gag co-localizes with Cav-1 at the PM. Co-
immuno-precipitations revealed that both proteins inter-
act presumably via a caveolin-binding domain (CBD)
within the aminoterminal region of MA. The CBD is
highly conserved in Gag of most γ-retroviruses and com-
petition experiments using CBD fusion proteins or a Cav-
1 dominant-negative mutant revealed that Gag-Cav-1
interaction modulates MLV production.
Results
Amphotropic and ecotropic murine leukemia virions 
incorporate Caveolin-1
Recently, we reported co-localization of Cav-1 and Env of
A-MLV [16] and presented hints for Cav-1 incorporation
into A-MLV released from mouse NIH 3T3 cells [19]. To
confirm our initial results and to extend our findings to
the ecotropic MoMLV we investigated whether Cav-1 is
included into released virions. For that purpose we ana-
lysed A-MLV and MoMLV propagated in NIH 3T3 cells.
Viruses were purified by ultracentrifugation followed by
sucrose gradient centrifugation. Viral proteins were sepa-
rated by SDS-PAGE and analysed by Western Blot using
anti-Cav-1 antibodies. Figure 1 demonstrates that Cav-1 is
incorporated into MoMLV (lane 3) as well as A-MLV (lane
4). A signal with the size expected for Cav-1 isoforms (21–
24kD) could be detected in processed virus samples (lane
3,4) which comigrates with positive control samples from
cell lysates (lane 1,2). Processed supernatants of mock-
infected non-virusproducing NIH 3T3 cells did not give
rise to a signal (data not shown, [19]). Therefore, both
MLV strains incorporate Cav-1 into the viral membrane,
presumably during the process of budding from lipid rafts
of NIH 3T3 cells.
Co-localization of MLV-Gag and caveolin-1
To address the question whether MLV Gag and Cav-1 co-
localize, we investigated NIH 3T3 and 293 cells trans-
fected with expression plasmids carrying Gag or Cav-1
fused C-terminally to fluorescent proteins (FPs) using
confocal microscopy. It has been shown that attachment
of GFP to the C-terminus of Cav-1 does not interfere with
its localization, fatty acylation or oligomerization proper-
ties [20-22]. Similarly, C-terminal fusions of FPs to Gag
have been proven to be valuable tools to study localiza-
tion, incorporation and budding of MLV Gag [23,24].Virology Journal 2006, 3:73 http://www.virologyj.com/content/3/1/73
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NIH 3T3 cell transfected with Cav-1-GFP, showed a typi-
cal surface staining and exhibited the expected expression
pattern, but also several scattered spots distributed
throughout the cytoplasm and a prominent accumulation
of Cav-1 positive membranes at the center of the cell in
perinuclear regions were observed (Fig. 2A). Gag-RFP
appeared in a punctate pattern distributed allover the
cytoplasm, accumulated in membranes in perinuclear
regions and at or close to the PM like beads on a string
(Fig. 2A and 2B). In 293 cells, which contain less endog-
eneous Cav-1 than NIH 3T3 cells [25] Cav-1-GFP as well
as Gag-RFP were concentrated in patches at the edge of the
cell, however, Cav-1-GFP accumulated predominantly in
a perinuclear region in the center of the cell. Gag-RFP ves-
icles were also concentrated in this region, however, to a
lesser extent (Data not shown). In cotransfected NIH 3T3
cells Gag-RFP and Cav-1-GFP spots co-localized to a cer-
tain extent at the PM and in perinuclear regions, but to a
much lesser extent in the cytoplasm (Fig. 2A). Interest-
ingly, when infected cells were used for the transfection
experiments the Cav-1-GFP and Gag-RFP fluorescence
patterns did not change considerably (see Additional file
1). However, in certain cases, Cav-1 predominantly
stacked in perinuclear regions, while the pattern of Gag-
RFP remained unaltered (data not shown).
In the experiments described endogenous Cav-1, even in
low levels, may compete with Cav-1-GFP expression.
Moreover, overexpression of Cav-1-GFP may favour stack-
ing of the GFP fusion protein in perinuclear regions.
Therefore, we repeated the experiments using Gag-RFP
transfected cells and stained endogenous Cav-1 using an
anti-Cav-1 antibody. Gag-RFP transfected NIH 3T3 cells
were fixed 46 h after transfection and immunostained
with rabbit anti-Cav-1 antibody and goat anti rabbit Alexa
488. Confocal optical sections taken through the cell
Colocalization studies using confocal microscopy Figure 2
Colocalization studies using confocal microscopy. A. 
Caveolin-1-GFP and GagRFP fusion proteins colocalize in 
transiently transfected NIH 3T3 cells predominantly at the 
plasma membrane. NIH 3T3 cells were co-transfected with 
Gag-RFP and caveolin-1 GFP plasmids, fixed 46 h later and 
analysed by confocal microscopy. B. Caveolin-1 and GagRFP 
colocalization in NIH3T3 cells. NIH3T3 transfected with 
GagRFP plasmid were fixed 46 h after transfection and 
stained for immunofluorescence rabbit anti-caveolin-
1antibody followed by goat anti-rabbit-Alexa 488 conjugate
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Caveolin-1 is incorporated into MLV virions Figure 1
Caveolin-1 is incorporated into MLV virions. Ecotropic 
MLV and amphotropic MLV were pelleted from supernatants 
of infected NIH3T3 cells and purified by sucrose gradient 
centrifugation and virions were lysed and subjected to SDS-
PAGE (10%) followed by Western blot analysis using rabbit 
anti Cav-1 as primary antibody. Lane 1: Cav-1 positive con-
trol, human carcinoma cell lysate; Lane 2: Cav-1 positive con-
trol, NIH 3T3 cell lysate. Lane3: Ecotropic MLV Lane 4: 
Amphotropic MLV. M Marker, molecular weight in kDa.
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every 0.5 μm revealed that Cav-1 as well as Gag-RFP are
localized at the PM (see Additional file 2). Especially, Gag-
RFP spots are scattered throughout the cytoplasm and
perinuclear regions. However, both, Gag-RFP and Cav-1,
co-localize in a dot-like pattern to a large extent at the PM
(Fig. 2B, see Additional file 2). To improve visualization
and to estimate the rate of co-localization 'correlation
plots' were created. Therefore, the green and red channel
were merged and co-localized pixels were highlighted in
white. Approximately 40–70% of Gag-RFP and Cav-1
were co-localized at the PM (see Additional file 3). In
addition, co-localization profiles revealed that, if not co-
localized, Cav-1 and Gag spots at the PM are situated
closely to another (see Additional file 4).
Taken together, our experiments reveal that Cav-1 and
MLV Gag co-localize predominantly at the PM and to
some degree in intracellular compartments. Moreover,
MLV infection or the presence of other retroviral proteins
does not influence the co-localization patterns.
Gag-MA contains a putative caveolin-1 binding domain, 
which is highly conserved among γ-retroviruses
Cav-1 binds to a variety of cellular proteins via its caveolin
scaffolding domain (CSD, aa82–101) [26]. Many of these
binding partners play a role in cellular signaling. Two con-
sensus domains for binding to Cav-1 (CBD) have been
defined by phage display techniques using CSD as bait
and a random peptide library [27]. Both consensus
sequences were rich in aromatic residues and exhibited a
characteristic spacing (ΦxxxxΦxxΦ; ΦxΦxxxxΦ; Φ = W, F,
Y). Interestingly, we identified a putative CBD motif in the
MA of MoMLV and A-MLV Gag precursors (Table 1) [19].
Strikingly, the motif is highly conserved within most γ-ret-
roviruses (Table 1) and is absent in Gag of other retrovi-
ruses.
Caveolin-1 interacts with Gag precursor of MLV
Gag-Cav-1 co-localization, the presence of the putative
CBD in MA of MLV and the high degree of conservation
among γ-retroviruses motivated us to investigate whether
the two proteins interact with each other. To determine
whether MA-Cav-1 interactions occur in cells two types of
binding experiments were carried out. In the first set co-
immunoprecipitation experiments were performed using
NIH 3T3 cells transfected with Gag-YFP or Gag-CFP
expression plasmids. In these plasmids YFP or CFP vari-
ants have been fused to the C-terminus of MoMLV Gag
[24]. Cells were lysed, Cav-1 was pulled down by an Cav-
1 antibody/proteinG and the precipitates were separated
by SDS PAGE (10%) and analyzed by Western Blot for
their Gag-YFP or Gag-CFP content (Fig. 3). In samples
transfected with Gag-CFP or Gag-YFP fusion plasmid
(lane 2, lane 3) specific signals appeared at the expected
size of 80 kD. No signals were detected in probes from
mock-transfected NIH 3T3 cells (lane 4) or NIH 3T3 cells
transfected with a GFP expression plasmid (lane 1), which
excludes cross-reactions with GFP and Cav-1 during
immunoprecipitation. Our data show that immunopre-
cipitation of Cav-1 results in recovery of a MLV Gag-Cav-
1 complex and strongly indicates that Cav-1 binds to MLV
Gag.
In another set of experiments biotinylated peptides were
used as baits for binding partners. The synthetic peptides
encompassed the putative CBD of MA (MoMLV) (KKR-
RWVTFCSAEWPTFNVGW-K-Biotin) or a consensus CBD
(RNVPPIFNDVYWIAFNVGAR-K-Biotin) [27]. After incu-
bation with the cell lysates, complexes were bound on
paramagnetic streptavidin beads. The eluate was sepa-
rated via SDS PAGE and Western Blots were probed with
polyclonal anti-Cav-1 antibody (Figure 4). Signals co-
migrating with the Cav-1 band of NIH 3T3 extracts (posi-
tive control) appeared when either the biotinylated CBD
of MA or a consensus CBD were incubated with the
extract, but no signal cold be detected from NIH3T3
extract alone. In addition, two signals of minor intensity
could be detected at 60 kD and 80 kD which may repre-
sent oligomeric forms of Cav-1.
The experiments demonstrate that a synthetic peptide
comprising the putative CBD of MA of MoMLV pulls
down Cav-1 as efficient as a consensus CBD peptide
defined by phage display [27]. Taken together both series
of experiments provide compelling evidence that MLV
Gag directly interacts with Cav-1.
CBD expression interferes with virus production
We next performed experiments designed to investigate
the biological significance of the Cav-1-Gag interaction.
We reasoned that overexpression of fusion proteins con-
taining the CBD of MA could block the interaction of Gag
with endogenous Cav-1. To study the effect on virus for-
mation expression plasmids were constructed encoding
GFP fused to the CBD of MA or the consensus CBD pep-
tide [27] as a positive control. Expression plasmids were
transiently transfected into A-MLV producing NIH3T3
cells and the effect of CBD overexpression on infective
virus production was determined by infectious titre assay
(Figure 5). Results of three experiments show that virus
production was reduced 5–10 fold upon CBD transfec-
tion. This suggests, that CBD overexpresssion competes
with endogenous Cav-1 for binding to Gag and that Cav-
1 indeed plays a functional role in A-MLV production.
A dominant negative caveolin-1 mutant down-modulates 
virus production
If endogenous Cav-1 is important for A-MLV production
overexpression of Cav-1 or the interaction with a scaffold-
ing-incompetent Cav-1 mutant should exert similar, neg-Virology Journal 2006, 3:73 http://www.virologyj.com/content/3/1/73
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ative effects on virus yield. To evaluate the role of Cav-1
the effect of overexpressing wild-type (wt) Cav-1 or the
dominant-negative Cav-1 mutant [28] on A-MLV virus
production was investigated in infected NIH 3T3 cells
which are known for their high Cav-1 content. Therefore,
wt Cav-1 or Cav-1 Mut SD expression plasmid were tran-
siently transfected into NIH 3T3 cells releasing a G418
resistant A-MLV and 48 hours after transfection viral titres
were determined on indicator cells. A significant reduc-
tion in virus titre was observed in Cav-1 Mut SD trans-
fected cells when compared to mock-transfected cells
(Figure 6). Interestingly, NIH 3T3 cells transfected with
the wt Cav-1 construct exhibited a similar reduction in
viral titre. These experiments suggest that inhibition of
Cav-1 function as well as overexpression interfere with
virus production and point to a discrete role of Cav-1 in
late viral processes.
Discussion
We presented evidence that MLV Gag interacts with Cav-1
and that this interaction influences virus assembly and
production. As another consequence of its interaction
with Gag, Cav-1 is incorporated into A-MLV and MoMLV
released from NIH 3T3 cells. Confocal fluorescence
microscopy revealed that Cav-1 and MLV Gag co-localize
predominantly in punctate patterns at the PM and to
lower extent in perinuclear regions of the cell. Sequence
comparisons uncovered a Cav-1 binding domain in the
matrix domain MA of the Gag precursor which is highly
conserved among γ-retroviruses. Subsequent binding
experiments using co-immunoprecipitation and a pull-
down assay revealed that Cav-1 directly interacts with
MLV-Gag. The interaction of Cav-1 with MA seems to play
an important role in virus production, as overexpression
of the CBD of MA considerably reduced the production of
infectious virus in NIH 3T3 cells. Furthermore, overex-
pression of both, wt Cav-1 and a dominant-negative Cav-
1 mutant, in A-MLV releasing NIH 3T3 cells resulted in a
considerable decrease of virus production.
Co-immunoprecipitation of Cav-1 Figure 3
Co-immunoprecipitation of Cav-1. Lysates from or 
transfected (lane 1–3) or mock-transfected (lane 4) NIH3T3 
cells were treated with rabbit anti Cav-1 followed by capture 
on paramagnetic protein G microbeads (μ column system, 
Miltenyi). Precipated proteins were separated by SDS-PAGE 
followed by Western Blot detection on PVDF membranes 
using an GFP antibody with GFP, YFP and CFP specifity. 
NIH3T3 lysates transfected with Lane1: GFP Plasmid; Lane 2: 
Gag-CFP; Lane 3: Gag-YFP Lane 4: mock; M Marker, molecu-
lar weight in kDa
 
 
 
Table 1: Putative caveolin-1 binding domains in the matrix protein of the Gag precursor of γ -retroviruses
Retrovirus AA* protein sequence† Accession No
Moloney MLV 31 KKRRWVTFCSAEWPTFNVGW PIR:FOMV1M
Sp2/0 xenotropic retrovirus 31 KKRRWVTFCSAEWPTFGVGW EMBL :X94150
Amphotropic MuLV 1313 31 KKRRWVTFCSAEWPTFNVGW GenBank:AF411814.1
Abelson MLV 31 KKRRWVTFCSAEWPTFNVGW Swiss-Prot:P03333
AKV MLV 31 KKRRWVTFCSAEWPTFNVGW Swiss-Prot:P03336
Rauscher MLV 31 RKRRWVTFCSAEWPTFNVGW GenBank:NP_044737
Friend MLV 31 RKRRWVTFCSAEWPTFNVGW Swiss-Prot:P26805
MAIDS related virus (BXH-2) 31 RKRRWVTFCSAEWPTFNVGW GenBank:AAB47858.1
MAIDS virus Duplan strain 31 KRRRWVTFCSVEWPSFNVGW EMBL:X14576
Gibbon ape leukemia virus SEATO 31 KKGKWQTFCSSEWPTFGVGW Swiss-Prot:21416
Gibbon ape leukemia virus X 31 RXGKWQTFCSSEWPTFGVRW GenBank:AAC80263
Simian sarcoma virus 31 RKEKWQTFCSSEWPTFGVGW PIR:FOMVGS
Moloney murine sarcoma virus 31 KKRRWVTFCSAEWPTFNVGW PIR:FOMVM
Endogenous koala retrovirus 31 RKGKWQTFCSSEWPTFEVGW GenBank:AAF15097
Porcine endogenous retrovirus 31 KKGPWQTFCASEWPTFDVGW GenBank:CAB65341
Mus dunni endogeneous retrovirus (MDEV) 31 RKGPWQTFCASEWPTFGVGW GenBank:AF053745
Mus musculus retrovirus (MmERV) 31 RKGPWQTFCTSEWPTFGVGW GenBank:AC005743
Woolly monkey sarcoma virus 31 RKEKWQTFCSSEWPTFGVGW Swiss-Prot :P03330
AA: Amino acid position of the first residue in the depicted sequences is indicated. Bold, CBD motif identified from consensus CBD motifs [27] 
which were rich in aromatic residues and exhibited a characteristic spacing (ΦxxxxΦxxΦ; ΦxΦxxxxΦ; Φ = W, F, Y).Virology Journal 2006, 3:73 http://www.virologyj.com/content/3/1/73
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The role of Cav-1 in the MLV life cycle
There are several lines of evidence that Cav-1 incorpora-
tion into virus and its interaction with Gag is of biological
relevance. First, the CBD is highly conserved within γ-ret-
roviruses. The strong selective pressure on preservation of
the sequence argues for performance of a specific function
within the viral life cycle. Second, perturbing the stochi-
ometry of the interaction between Gag and Cav-1 by
expression of wt Cav-1, a dominant negative Cav-1
mutant or fusion proteins carrying the CBD impaired viral
life cycle and resulted in considerable decrease in viral
yield. The inhibition is a specific process rather than an
effect exhibited by interfering with cell viability or physi-
ology. Obviously, perturbation interferes with late proc-
esses in viral replication. Third, further hints for the
importance of the CBD of MA arise from deletion or
linker scanning mutational analysis of the MA protein
function performed earlier [5,29-31]. Strikingly, deletion
or linker scanning mutation encompassing the region of
the putative CBD resulted in dislocation of Gag and
decrease in virus yield. For example, mutation of the tryp-
tophan residues in a 'hydrophobic region', especially
those which are part of (W43) or are close (W35, W50) to
the putative CBD of MLV Gag (amino acids 38–46 of the
Gag precursor) resulted in a dramatic loss in the produc-
tion of infectious MoMLV and decrease in viral reverse
transcriptase (RT) activity of released viruses. Mutations in
residues 40, 44, 45 and 46 resulted in a 20 fold decrease
Influence of expression of cav-1 wild-type and dominant-neg- ative mutant cav-1 on MLV-A titres in NIH3T3 cells Figure 6
Influence of expression of cav-1 wild-type and domi-
nant-negative mutant cav-1 on MLV-A titres in 
NIH3T3 cells. MLV-A infected NIH3T3 cells were tran-
siently transfected with expression plasmids containing wt 
cav-1 cDNA or a dominant-negative mutant carrying to 
mutations in the scaffolding domain [28]. Titres were deter-
mined from supernatants 48 h after transfection on indicator 
cells according to Spearman and Karber as described in 
Materials and Methods. Normalized values are shown. In 
each of three independent experiments mock-transfected 
NIH-MLV-A were used for normalization. Standard devia-
tions are shown.
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Effect of CBD expression on MLV production Figure 5
Effect of CBD expression on MLV production. Expres-
sion plasmids carrying cloned caveolin-1 binding domains 
were transfected into 4070A infected NIH3T3 cells and the 
effect on virus release was determined by infectious titer 
assay as described in Material and Methods. Competition 
experiments involved the putative CBD domain in MA of 
MLVs or a consensus CBD derived from display analysis [27].
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Pull down experiments using CBD peptides Figure 4
Pull down experiments using CBD peptides. 20 mM 
biotinylated peptide encompassing either the putative binding 
domain within MA or a consensus binding motif were inocu-
lated with 50 μl NIH3T3 cell lysate for 90minutes (from 2 ml 
lysate of semiconfluent T75 culture flask). Complexes were 
immobilized using 10 μl streptavidin coated paramagnetic 
microbeads and μ column (Miltenyi). Washed samples were 
eluted and 15 μl of 80 μl eluate were separated by SDS-
PAGE, blotted to PVDFmembrane and probed with anti-
caveolin-1 antibody. lane 1: NIH 3T3 lysate, no peptide 
added ; lane 2 : NIH3T3 lysate with biotinylated CBD-MA 
peptide; lane 3: NIH 3T3 incubated with biotinylated consen-
sus CBD peptide; lane 3: positive control, NIH3T3 lysate, 
non-processed. Molecular weights are depicted (kDa).
 Virology Journal 2006, 3:73 http://www.virologyj.com/content/3/1/73
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in viral infectivity compared to the wt virus. As in this
analysis the Gag localization pattern of tryptophan
mutants differs considerably from wt Gag – the mutant
Gag localizes exclusively in perinuclear regions in diffuse
manner – the CBD tryptophan residues in MA identified
in our investigation have been suggested to play an impor-
tant role in Gag transport [5].
Positioning of Gag to cellular membranes
It is conceivable that Cav-1-Gag interaction is crucial for
positioning MLV Gag at the PM, special PM domains like
lipid rafts and/or the membrane of intracellular compart-
ments or vesicles. If Cav-1 functions in that way it would
function as a Gag receptor. The existence of a Gag receptor
has been postulated, since the membrane insertion reac-
tion is highly efficient and specific [32]. Retroviral Gag
precursor proteins become anchored into the cytoplasmic
leaflet of the PM via a dual motif consisting of amino ter-
minal myristoylation and a cluster of basic residues [2-
6,8]. The dual motif is not expected to result in a very spe-
cific insertion, as myristoylated proteins are found in sev-
eral compartments and acidic phospholipids, which
interact with basic amino acids, are not restricted to the
PM.
Interestingly, Cav-1 interaction with proteins substitutes
for fatty acylation in certain cases and has been described
to help in localization of proteins to lipid rafts. Partition-
ing of acyl side chains into liquid-ordered phase domains
has been suggested as mechanism for targeting of proteins
to lipid rafts [33]. However, although fatty acylation is
necessary for membrane association of proteins in gen-
eral, there is certain evidence that the normal requirement
for acylation for localization in lipid rafts can be over-
come by other molecules [34]. Studies with acyl-modified
GFPs showed that N-terminal protein acylation only con-
ferred localization to cholesterol and sphingolipid-
enriched membranes but not to lipid rafts or caveolae,
suggesting that protein-protein interactions may be
required for efficient raft association [34]. Also, acylated
vesicular stomatitis virus (VSV) G protein and Rous sar-
coma virus (RSV) Env were not associated with lipid raft
[35]. Interestingly, it has been shown, that overexpression
of a recombinant caveolin in intact cells is sufficient to
functionally recruit a non-farnesylated Ras mutant onto
membranes thereby overcoming the normal requirement
for lipid modification of Ras. This suggests that caveolin
may function as scaffolding protein to localize or seques-
ter caveolin interacting proteins (e.g. wt Ras) within cave-
olin-rich microdomains of the PM [34]. Interestingly,
caveolin is palmitoylated at 3 residues, but fatty acylation
is not necessary for its caveolae localization [36]. Moreo-
ver, Pr60 Gag of murine AIDS virus lacking the myristoyl
modification is not dispersed in the cytoplasma like
MoMLV Pr65 Gag, but attaches loosely to the PM [37].
Overexpression of caveolin-1 in cells infected with a myr-
istoylation minus MLV mutant and analysis of Gag local-
ization and transport of mutants encompassing the MA-
CBD motif and neighbourhood will elucidate more
details on the importance of caveolin in Gag membrane
attachment.
Presently, we do not know how many functions Cav-1
exerts in the MLV replication cycle. However, our results
suggest that Cav-1 presumably is responsible for Gag
localization within lipid rafts. According to our present
understanding Cav-1 containing lipid rafts rather than
caveolae itself seem to be most suitable for assembly and
budding, as invagination, endocytosis and the compact
coat of caveolae would exclude virus budding. Such an
interpretation is supported by the characteristic localiza-
tion patterns exhibited in profile analysis where co-locali-
zation and to some extent nearby localization of Gag and
Cav-1 at the PM could be observed and a release process
may be assumed when caveolae are formed upon Cav-1
oligomerization from preformed multimers. Further-
more, once localized, binding to Cav-1 may initiate oli-
gomerization of further Gag molecules, leading to Gag
clustering, a crucial oligomerization step in virus forma-
tion. Possibly, Cav-1 may also play a role in the transport
of Gag to intracellular vesicles like MVBs or to the PM,
either membrane bound, in its soluble form or asscoci-
ated with lipid droplets [38]. Finally, due to the fact that
Cav-1 co-localizes with MLV-Env and Gag, it may serve as
a Gag-Env bridging molecule. However, unlike in RSV or
HIV, there is little evidence for such a close linkage in the
case of MLV [39,40].
Taken together, it is likely that Cav-1 functions to locate
MLV Gag to the PM, and due to the co-localization of Env,
Cav-1 and GM1 [16], a marker for lipid rafts, a role for
Cav-1 in Gag positioning in lipid rafts is highly probable.
It is tantalizing to speculate, that this will also hold for
Gag of related retroviruses listed in Table 1 which contain
the CBD motif.
Recently, Hovanessian et al. reported that HIV-gp41, the
transmembrane subunit of the viral spike protein, also
binds to caveolin-1 via a CBD motif located at position
622–633 of gp41 [41]. The CBD in gp41 is highly con-
served within HIV-isolates and SIV lentivirus. However,
the binding region was mapped to the lentiviral ectodo-
main of the transmembrane protein and the function of
this putative interaction has not been revealed. Due to the
external location of the CBD Cav-1 incorporation into vir-
ions has not been observed [41].
Conclusion
Taken together our data demonstrate that Cav-1 co-local-
izes with Gag of murine leukemia viruses at the PM andVirology Journal 2006, 3:73 http://www.virologyj.com/content/3/1/73
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interacts with this precursor protein via a CBD in MA. As
CBD competition or overexpression of a dominant-nega-
tive Cav-1 mutant affects virus production, Cav-1 plays
distinct roles in virus assembly.
Methods
Cells and viruses, cell culture
NIH 3T3 cells (ATCC CRL-1658) and 293 cells (ATCC
CRL 1573) were propagated in DMEM supplemented
with antibiotics, glutamine and 10% FCS. Cells were
grown at 37°C, 5% CO2 and 95% humidity.
Plasmids, transfections and helper virus approach
pMLV ampho and pMLVeco contain the complete
genome of amphotropic MLV or ecotropic MLV cloned
into pBluescript (Genethon, France, received via J.-C.
Pages). pCaveolin-1-GFP contains canine cav-1 cDNA fol-
lowed in frame by EGFP [21]. pCFPgag and pYFPgag are
in frame fusion of MoMLV Gag with CFP or YFP [24].
pMLVgagRFP contains the MoMLV Gag ORF inserted into
the BamHI/AgeI site of pmRFP-N1 (R.Tsien)[23]. pCSD-
MLV and pCSD-Consensus were created by insertion of an
oligonucleotide coding for the putatitive CBD domain in
MA and a oligonucleotide coding for the consensus CBD
(see peptides), respectively, into the EcoRI site of pTarget
(Promega). pLEIN contains a bicistronic MLV vector har-
boring EGFP and the neonmycin resistance gene (Clon-
tech). pCav-WT contains a myc-tagged canine Cav-1
cDNA copy cloned into pCIS2 [28]. pCav-MUT contains
point mutations (F92A V94A) in the scaffolding domain
of canine cav-1 cDNA [28]. Transfections were performed
using purified DNA (Quiagen kit) and the calcium-phos-
phate coprecitation method. MLV producing NIH3T3
cells resulted from calcium phosphate transfection of
pMLVampho or pMLV eco, respectively, and subsequent
infection of NIH3T3 with the respective replication com-
petent MLV. G418 resistant viruses were created by
cotransfection of pMLVs with pLEIN, which contains a
bicistronic MLV vector harboring EGFP and the neomycin
resistance gene (Clontech).
Virus isolation
MLVs were precipitated from cleared supernatants of MLV
infected NIH 3T3 cells from three T75 flasks (2000 rpm,
Heraeus Megafuge 1R) by centrifugation (3 h, 17000 rpm
Sorvall FAD-20C). Virus pellets were resuspended in TNE
and purified by sucrose gradient centrifugation (25–40%
discontinuous, O/N 35 000 rpm). Viruses banding at
approx. 35% sucrose were collected and precipitated at
40000 rpm for 3 h. All steps were carried out at 4°C. Virus
pellets were resuspended in 100 μl TNE and stored at -
20°C.
Virus titration
Virus mediating G418 resistance were created by the
helper approach and titrated on NIH 3T3 indicator cells
(750 c per well, microtiter plate 96 well, 8fold determina-
tion) according to the method of Spearman and Kaerber
[42]. Serial dilutions of filtered supernatants (24 h pro-
duction) were prepared and infection of indicator cells
was performed in the presence of 8 μg/ml polybrene.
Selective medium was applied 2d after infection and clone
forming units (cfu) were determined 10 d after infection
by staining of cells with crystal violet.
Peptide synthesis
Biotin-labelled CBD peptides were synthesized by the
group of Werner Tegge (Chemical Biology, GBF, Braun-
schweig, Germany). CBD-MA contained the putative CBD
binding domain in MA (sequence AcRNVPPIFNDVY-
WIAFNVGAR-K-Biotin), CDB consensus a consensus Cav-
1 binding domain deviated from phage display experi-
ments (sequence AcKKRWVTFCSAEWPTFNVGW-K-
Biotin) [27].
Lysis of cells and viruses
Cells or viruses were treated with lysis buffer (10 mM Tris
pH7.5, 50 mM NaCl, 1% Triton X100, 60 mM octylgluco-
side (Roche), 1 mM aprotinin, 1 mM leupeptin, 1 mM
PMSF) at 4°C for 30 min followed by centrifugation in an
Eppendorf centrifuge at 15000 rpm. Cleared supernatants
were processed further or stored at -20°C.
Protein/protein binding assays
Co-immunoprecipitation
Cell lysates were incubated with rabbit anti-caveolin-1
antibody (1:2000) at 4°C for 1 h followed by incubation
with 50 μl Protein G-microbeads at 4°C for 1 h and sub-
sequent application to prewashed μ columns (Miltenyi).
After four washing steps (200 μl lysis buffer) bound pro-
teins were eluted with 70 μl sample buffer preheated to
95°C.
Pull-down assays
Cell lysates were incubated with 20 μM biotinylated CBD
motif peptides at 4°C for 90 min followed by treatment
with 10 ml streptavidin coated microbeads (Miltenyi Bio-
tec). Lysate was applied on prewashed μ columns and
after washing five times with 200 μl lysis buffer the pro-
teins were eluted with 70 μl sample buffer preheated to
95°C.
SDS-PAGE and Western Blot analysis
Proteins were separated by SDS-PAGE (12%) at 100 V for
2 h. Semidry blotting was used for subsequent protein
transfer to PVDF membranes. After O/N blocking with
Starting Block (PerBio), primary antibody (rabbit anti-
caveolin-1 or mouse anti-GFP diluted 1:2000 in startingVirology Journal 2006, 3:73 http://www.virologyj.com/content/3/1/73
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block buffer containing 0.05% Tween20) was applied at
room temperature with constant shaking for 1 h. Mem-
branes were washed 3 times for 10 min in TBS/
0.05%Tween20 followed by incubation with the second-
ary antibody (goat anti-rabbit HRP 1:100,000 or goat-anti
mouse HRP 1:1,000,000). After 5 additional washes
membranes were incubated in luminal/enhancer solution
(PerBio).
Immunostaining and confocal immunofluorescence
Cells were either fixed with 4% formaldehyde (cotransfec-
tions of fluorescent fusion proteins) or fixed/permeabi-
lized with cold methanol/aceton (Gag-RFP, endogenous
Cav-1) on coverslips. Blocking (2% goat serum in PBS for
20 min) was followed by incubation with the primary rab-
bit anti-caveolin-1 antibody (Transduction Laboratories,
1:300 diluted in PBS/2% goat serum) for 1 h. Excess anti-
body was removed by washing three times with PBS con-
taining 0.02% TritonX-100. To detect the primary
antibody, the samples were incubated with an Alexa Fluor
488-labeled goat-anti-rabbit secondary antibody (Molec-
ular Probes, 1:300 dilution, Alexa Fluor 488 F(ab')2 con-
jugate IgG (H+L)). The coverslips were washed again and
then mounted onto glass slides using fluorescent mount-
ing medium (DAKO). Confocal imaging was performed
with a Zeiss LSM 510META laser scanning microscope
(inverted Axiovert 200 M microscope) using a Plan-
Apochromat 100× oil immersion objective (1.3 numeric
apertures). EGFP or Alexa Fluor 488-labelled antigens
were excited with an argon laser at 488 nm, and emission
was monitored using a 505–530 nm bandpass filter. For
RFP visualization a HeNe laser at 543 nm and a 560–615
nm bandpass filter were used.
Competition and inhibition experiments
Plasmids pCSD-consensus or pCSD-MLV were stably
introduced into A-MLV/pLEIN infected NIH3T3 cells by
calcium phosphate precipitation. Virus titers were deter-
mined from pooled clones.
Plasmids pCav-wt or pCav-Mut were transiently intro-
duced into A-MLV/pLEIN infected NIH3T3 cells by cal-
cium phosphate precipitation. Virus titers were
determined 2 d after transfection.
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rabbit anti-caveolin-1antibody followed by goat anti-rabbit-Alexa 488 
conjugate.
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Colocalization of Cav-1 and Gag RFP in transfected NIH3T3. Z-Stack 
images. NIH3T3 transfected with GagRFP plasmid were fixed 46 h after 
transfection and stained for immunofluorescence rabbit anti-caveolin-
1antibody followed by goat anti-rabbit-Alexa 488 conjugate. Scanning by 
confocal microscopy from bottom to top, distance or 0.5 μm each.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-
422X-3-73-S2.doc]
Additional File 3
Correlation plot and colocalization points of Cav-1 and Gag RFP flu-
orescence in NIH3T3 cells. The software merges the red (Ch3-T2) and 
green channel (Ch2-T1) and highlights colocalized pixels in white. Pixels 
are considered colocalized when their intensity is higher than the thresh-
old of their channels (red label), which was defined by analysing the dis-
tribution frequency.
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Additional File 4
Profile analysis of Cav-1 and Gag RFP fluorescence in NIH3T3 cells. 
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(B) in the channels detecting GagRFP (red) and caveolin-1 (green) along 
the red arrow (A).
Click here for file
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